West Pharmaceutical Services Inc (WST)
316.59
-4.29
(-1.34%)
USD |
NYSE |
Nov 22, 16:00
316.53
-0.06
(-0.02%)
After-Hours: 20:00
West Pharmaceutical Services Cash from Financing (Quarterly): -64.40M for Sept. 30, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -64.40M |
| June 30, 2024 | -218.30M |
| March 31, 2024 | -271.00M |
| December 31, 2023 | -189.50M |
| September 30, 2023 | -22.30M |
| June 30, 2023 | -176.80M |
| March 31, 2023 | -71.00M |
| December 31, 2022 | -9.50M |
| September 30, 2022 | -75.20M |
| June 30, 2022 | -36.20M |
| March 31, 2022 | -172.70M |
| December 31, 2021 | -6.20M |
| September 30, 2021 | -5.80M |
| June 30, 2021 | 0.30M |
| March 31, 2021 | -156.40M |
| December 31, 2020 | -8.70M |
| September 30, 2020 | -7.20M |
| June 30, 2020 | -0.90M |
| March 31, 2020 | -120.30M |
| December 31, 2019 | 51.00M |
| September 30, 2019 | -0.40M |
| June 30, 2019 | 3.10M |
| March 31, 2019 | -90.50M |
| December 31, 2018 | -8.20M |
| September 30, 2018 | 10.10M |
| Date | Value |
|---|---|
| June 30, 2018 | -25.70M |
| March 31, 2018 | -56.90M |
| December 31, 2017 | -86.50M |
| September 30, 2017 | -3.00M |
| June 30, 2017 | 2.30M |
| March 31, 2017 | -21.80M |
| December 31, 2016 | -26.40M |
| September 30, 2016 | -15.00M |
| June 30, 2016 | -7.40M |
| March 31, 2016 | -65.10M |
| December 31, 2015 | -1.60M |
| September 30, 2015 | -30.40M |
| June 30, 2015 | -10.70M |
| March 31, 2015 | 1.20M |
| December 31, 2014 | -1.80M |
| September 30, 2014 | -10.00M |
| June 30, 2014 | -45.20M |
| March 31, 2014 | 26.20M |
| December 31, 2013 | -23.50M |
| September 30, 2013 | 3.10M |
| June 30, 2013 | -40.20M |
| March 31, 2013 | 55.50M |
| December 31, 2012 | -29.50M |
| September 30, 2012 | 7.70M |
| June 30, 2012 | -5.80M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-271.00M
Minimum
Mar 2024
51.00M
Maximum
Dec 2019
-78.06M
Average
-50.30M
Median
Cash from Financing (Quarterly) Benchmarks
| Repligen Corp | -69.60M |
| Perspective Therapeutics Inc | 0.628M |
| Retractable Technologies Inc | -0.1343M |
| Xtant Medical Holdings Inc | 5.314M |
| Catheter Precision Inc | 4.02M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 180.10M |
| Cash from Investing (Quarterly) | -82.10M |
| Free Cash Flow | 321.60M |
| Free Cash Flow Per Share (Quarterly) | 1.346 |
| Free Cash Flow to Equity (Quarterly) | 102.00M |
| Free Cash Flow to Firm (Quarterly) | 98.80M |
| Free Cash Flow Yield | 1.37% |